A.1. Aslan Kayiran M, Karadag AS et al. Antibiotic Resistance in Acne: Mechanisms, Complications and Management.
Am J Clin Dermatol. 2020;21(6):813-819 · PMID: 32889707
A.2. Kayiran MA, Cebeci F, Zindanci I et al. Dermoscopy of nevus comedonicus.
North Clin Istanb. 2018;6(4):401-402 · PMID: 31909387
A.3. Karadag AS,
Kayıran MA, Parish LC. Probiotics and Prebiotics-The Good Germs: A Dermatologic Perspective.
Skinmed. 2020;18(1):10-13 · PMID: 32167449
A.4. Kayiran MA, Akdeniz N. Diagnosis and treatment of urticaria in primary care.
North Clin Istanb. 2019;6(1):93-99 · PMID: 31180381
A.5. Aslan Kayiran M, Uzunçakmak TK, Cebeci F et al. Dermoscopic features of Orf disease.
Int J Dermatol. 2018;57(1):115-116 · PMID: 29057465
A.6. Karadag AS,
Aslan Kayiran M, Wollina U. How dermatology has changed in the COVID-19 pandemic.
Clin Dermatol. 2021;39(3):457-460 · PMID: 34518004
A.7. Aslan Kayiran M, Karadag AS, Jafferany M. Psychodermatology of acne: Dermatologist's guide to inner side of acne and management approach.
Dermatol Ther. 2020;33(6):e14150 · PMID: 32770727
A.8. Aslan Kayiran M, Karadağ AS, Alyamaç G et al. Rates of skincare product and cosmetic procedure use in patients with acne vulgaris: A multicenter study with 1,755 patients.
J Cosmet Dermatol. 2022;21(6):2566-2576 · PMID: 34520610
A.9. Karadağ AS, Cebeci F,
Aslan Kayiran M et al. Fusarium solani infection in a diabetic patient treated with itraconazole and debridement.
Dermatol Ther. 2020;33(6):e14203 · PMID: 32829501
A.10. Aslan Kayiran M, Cebeci F, Erdemir VA et al. Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans.
Dermatol Ther. 2021;34(1):e14740 · PMID: 33404148
A.11. Aslan Kayiran M, Karadağ AS, Alyamaç G et al. Social media use in patients with acne vulgaris: What do patients expect from social media?
J Cosmet Dermatol. 2021;20(8):2556-2564 · PMID: 34087036
A.12. Ozkok Akbulut T, Topaloglu Demir F,
Aslan Kayiran M et al. Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real-life multicenter study.
Int J Dermatol. 2021;60(9):1140-1147 · PMID: 34013975
A.13. Karadag AS,
Aslan Kayiran M, Lotti T, Wollina U. Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days.
Dermatol Ther. 2020;33(5):e13686 · PMID: 32458530
A.14. Aslan Kayiran M, Karadağ AS, Küçük Y et al. Are clinicians successful in diagnosing cutaneous adnexal tumors? A retrospective, clinicopathological study.
Turk J Med Sci. 2020;50(4):832-843 · PMID: 32283901
A.15. Aslan Kayiran M, Erdemir AV, Dağdelen D et al. A rare fungal infection of infants: a diffuse case of mucocutaneous candidiasis.
Int J Dermatol. 2020;59(2):259-262 · PMID: 31498879
A.16. Aslan Kayiran M, Kara Polat A, Alyamaç G et al. Has the COVID-19 pandemic changed attitudes and behaviors concerning cosmetic care and procedures? A multicenter study with 1437 participants.
J Cosmet Dermatol. 2021;20(10):3121-3127 · PMID: 34460987
A.17. Aslan Kayiran M, Karadağ AS, Mutlu HH et al. Comparison of dermatologists and family physicians in terms of prescribing antibiotics for the treatment of acne vulgaris.
Dermatol Ther. 2020;33(6):e13973 · PMID: 32621767
A.18. Polat AK, Topal IO,
Aslan Kayiran M et al. Drug survival and safety profile of acitretin monotherapy in patients with psoriasis: A multicenter retrospective study.
Dermatol Ther. 2021;34(2):e14834 · DOI: 10.1111/dth.14834
A.19. Aslan Kayiran M, Özkul E, Gürel MS. Tattoos: Why do we get? What is our attitude?
Turkish Journal of Dermatology. 2020;14(1):18-22 · DOI: 10.4103/TJD.TJD_46_19
A.20. Aslan Kayiran M, Karadag AS, Wollina U. Approach to skin malignancies in COVID-19 pandemic days.
J Biol Regul Homeost Agents. 2020;34(6):1977-1982 · DOI: 10.23812/20-344-E
A.21. Aslan Kayiran M, Gürel MS, Kuru BC, Zındancı I. A rare case of neurocutaneous disorders of the newborn: Incontinentia pigmenti.
Indian J Paediatr Dermatol. 2018;19(1):68-70 · DOI: 10.4103/ijpd.IJPD_135_16
A.22. Karadag AS,
Aslan Kayiran M, Wen-Chieh C et al. Antibiotic resistance in acne: changes, consequences and concerns.
J Eur Acad Dermatol Venereol. 2021;35(1):73-78 · DOI: 10.1111/jdv.16686
A.23. Aslan Kayiran M, Cebeci F, Karadag AS et al. Disease Severity and The Effect of Disease Severity on Quality of Life in Patients with Acne Vulgaris.
Istanbul Medical Journal. 2019;20(1):80-81 · DOI: 10.4274/imj.galenos.2018.43179
A.24. Söylemez T, Simsek BC,
Aslan Kayiran M, Haspolat Y. Merkel Hücreli Karsinom: Olgu Sunumu.
Güncel Patoloji Dergisi. 2019;3(2):109-111 · DOI: 10.5146/jcpath.2019.53
A.25. Aslan Kayiran M, Dervis E. Serum Lipoprotein(a) and Lipid Levels in Patients with Chronic Plaque Type Psoriasis.
Haydarpasa Numune Medical Journal. 2018;58(4):210-213 · DOI: 10.14744/hnhj.2018.50455
A.26. Aslan Kayiran M, Akdeniz N. Intradermal Testler (Tip I Allerji Testleri, Tip IV Allerji Testleri).
Türkiye Klinikleri Dermatoloji – Özel Konular. 2017;10(1):13-18
A.27. Aslan Kayiran M, Balaban D, Karaoglu A, Köslü A. Fokal Hiperhidrozun Intradermal Botulinum Toksin Enjeksiyonuyla Tedavisi.
Türkderm – Deri Hastalıkları ve Frengi Arşivi. 2006;40(1):17-19
A.28. Kayiran MA, Şahin AS, Simsek BC. A Lesion Surrounded by the Rainbow: Merkel Cell Carcinoma.
Dermatol Pract Concept. 2024;14(2):e2024064 · PMID: 38810066
A.29. Aslan Kayiran M, Karadağ AS, Oğuz Topal İ et al. Patients' Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients.
Dermatol Pract Concept. 2022;12(4):e2022190 · DOI: 10.5826/dpc.1204a190
A.30. Topaloğlu Demir F, Polat Ekinci A,
Aslan Kayiran M et al. Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic.
J Cosmet Dermatol. 2023;22(3):722-731 · PMID: 36630728
A.31. Kayiran MA, Sahin E, Koçoğlu E et al. Is cutaneous microbiota a player in disease pathogenesis? Comparison of cutaneous microbiota in psoriasis and seborrheic dermatitis with scalp involvement.
Indian J Dermatol Venereol Leprol. 2022;88(6):738-748 · PMID: 35389020
A.32. Cebeci F, Turgut Erdemir VA, Gürel MS, Akdeniz N,
Aslan Kayiran M. Crusted scabies in a child with down syndrome.
J Cosmet Dermatol. 2022;21(11):6466-6467 · PMID: 35599632
A.33. Aslan Kayiran M, Wang JV, Karadag AS. Papulosquamous annular diseases.
Clin Dermatol. 2022;40(5):441-449 · PMID: 34979266
A.34. Aslan Kayiran M, Karadağ AS, Oğuz Topal İ et al. Habits of Using Social Media and Seeking Information About Dermatological Diseases.
J Cosmet Dermatol. 2022 · DOI: 10.1111/jocd.15185
A.35. Kayıran A,
Aslan Kayiran M, Akdeniz N, Demirkesen C. Coexistence of osteoma cutis and seborrheic keratosis in a patient after botulinum toxin injection.
J Cosmet Dermatol. 2022;21(1):407-409 · PMID: 34716640
A.36. Kayiran MA, Karadağ AS, Alyamaç G et al. Use of Complementary and Alternative Medicine and Cosmetic Procedures in Acne Vulgaris Patients.
J Cosmet Dermatol. 2022 · DOI: 10.1111/jocd.14582
A.37. Aksoy H, Altıntaş Kakşi S, Gönüllü Ö,
Aslan Kayiran M, Erdemir VA. Biologic therapy increases Demodex density in psoriasis patients.
Int J Dermatol. 2024;63(9):1193-1199 · PMID: 38650106
A.38. Aksoy H,
Aslan Kayiran M, Dede Y et al. The effect of phototherapy on Demodex density: a case-control study.
Int J Dermatol. 2024;63(2):201-206 · PMID: 38234255
A.39. Kutlu Ö, Karadağ AS,
Kayiran MA et al. Epidemiological and clinical features of acne vulgaris: A multicenter study.
J Cosmet Dermatol. 2023 · DOI: 10.1111/jocd.15733
A.40. Aksoy H,
Aslan Kayiran M, Özger H. Comparison of Topical Treatment Preferences of Physicians in Dermatological Diseases.
European Journal of Therapeutics. 2023;29(4):712-720 · DOI: 10.58600/eurjther1859
A.41. Aksoy H, Cebeci Kahraman F,
Aslan Kayiran M et al. Dermoscopic Diagnosis of a Non-Pigmented Skin Tumor: Eccrine Poroma.
European Journal of Therapeutics. 2023;29(4):961-963
A.42. Güldiken Doğruel G, Atış G,
Aslan Kayiran M et al. Self-Induced Nail Disorders.
Int J Dermatol. 2024 · DOI: 10.1111/ijd.17364